Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients - Concepedia

Concepedia

Publication | Open Access

Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients

DOI Full Paper Access

84

Citations

22

References

2019

Year

Francesco Tovoli, Luca Ielasi, Andrea Casadei‐Gardini, Alessandro Granito, Francesco Giuseppe Foschi, Giulia Rovesti, Giulia Negrini, Giulia Orsi, Matteo Renzulli, Fabio Piscaglia

Journal of Hepatology

Adverse EventsHepatologyHepatocellular Carcinoma PatientsMedicinePharmacotherapyLiver CancerCancer TreatmentOncologyRadiation OncologyHepatocellular CarcinomaTailored Sorafenib

References

	Year	Citations

Page 1

Page 1